Identifying severe bacterial infection in children with fever without source

References

• Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr.94(2), 155–158 (2005).
   PubMedGoogle Scholar
• Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr. Infect. Dis. J.26(8), 672–677 (2007).
   PubMed Web of Science ®Google Scholar
• Pratt A, Attia MW. Duration of fever and markers of serious bacterial infection in young febrile children. Pediatr. Int.49(1), 31–35 (2007).
   PubMed Web of Science ®Google Scholar
• Galetto-Lacour A, Gervaix A, Zamora SA et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur. J. Pediatr.160(2), 95–100 (2001).
   PubMedGoogle Scholar
• Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics112(5), 1054–1060 (2003).
   PubMed Web of Science ®Google Scholar
• Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics108(6), 1275–1279 (2001).
   PubMed Web of Science ®Google Scholar
• Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch. Pediatr. Adolesc. Med.156(9), 905–909 (2002).
   PubMedGoogle Scholar
• Hoberman A, Wald ER. Urinary tract infections in young febrile children. Pediatr. Infect. Dis. J.16(1), 11–17 (1997).
   PubMed Web of Science ®Google Scholar
• Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J. Pediatr.123(1), 17–23 (1993).
   PubMed Web of Science ®Google Scholar
• Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics102(2), e16 (1998).
   PubMed Web of Science ®Google Scholar
• Taylor JA, Del Beccaro M, Done S, Winters W. Establishing clinically relevant standards for tachypnea in febrile children younger than 2 years. Arch. Pediatr. Adolesc. Med.149(3), 283–287 (1995).
   PubMedGoogle Scholar
• Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad. Emerg. Med.14(3), 243–249 (2007).
   PubMed Web of Science ®Google Scholar
• Fleisher GR, Rosenberg N, Vinci R et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J. Pediatr.124(4), 504–512 (1994).
   PubMedGoogle Scholar
• Jaffe DM, Tanz RR, Davis AT, Henretig F, Fleisher G. Antibiotic administration to treat possible occult bacteremia in febrile children. N. Engl. J. Med.317(19), 1175–1180 (1987).
   PubMedGoogle Scholar
• Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann. Emerg. Med.31(6), 679–687 (1998).
   PubMed Web of Science ®Google Scholar
• Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children’s Hospital Emergency Department and Urgent Care Center. Arch. Pediatr. Adolesc. Med.158(7), 671–675 (2004).
   PubMedGoogle Scholar
• Herz AM, Greenhow TL, Alcantara J et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr. Infect. Dis. J.25(4), 293–300 (2006).
   PubMed Web of Science ®Google Scholar
• Eagles D, Stiell IG, Clement CM et al. International survey of emergency physicians’ priorities for clinical decision rules. Acad. Emerg. Med.15(2), 177–182 (2008).
   PubMedGoogle Scholar
• Bonadio WA, Hennes H, Smith D et al. Reliability of observation variables in distinguishing infectious outcome of febrile young infants. Pediatr. Infect. Dis. J.12(2), 111–114 (1993).
   PubMedGoogle Scholar
• McCarthy PL, Sharpe MR, Spiesel SZ et al. Observation scales to identify serious illness in febrile children. Pediatrics70(5), 802–809 (1982).
   PubMedGoogle Scholar
• Hewson P, Poulakis Z, Jarman F et al. Clinical markers of serious illness in young infants: a multicentre follow-up study. J. Paediatr. Child. Health.36(3), 221–225 (2000).
   PubMedGoogle Scholar
• Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, Fernandez Pou J. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr. Infect. Dis. J.22(10), 895–903 (2003).
   PubMedGoogle Scholar
• Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet375(9717), 834–845 (2010).
   PubMed Web of Science ®Google Scholar
• Craig JC, Williams GJ, Jones M et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ340, c1594 (2010).
   PubMed Web of Science ®Google Scholar
• Thompson M, Coad N, Harnden A, Mayon-White R, Perera R, Mant D. How well do vital signs identify children with serious infections in paediatric emergency care? Arch. Dis. Child.94(11), 888–893 (2009).
   PubMedGoogle Scholar
• van Veen M, Steyerberg EW, Ruige M et al. Manchester triage system in paediatric emergency care: prospective observational study. BMJ337, a1501 (2008).
   PubMedGoogle Scholar
• Kuppermann N. Occult bacteremia in young febrile children. Pediatr. Clin. North Am.46(6), 1073–1109 (1999).
   PubMed Web of Science ®Google Scholar
• Baraff LJ, Bass JW, Fleisher GR et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann. Emerg. Med.22(7), 1198–1210 (1993).
   PubMed Web of Science ®Google Scholar
• Baraff LJ. Management of fever without source in infants and children. Ann. Emerg. Med.36(6), 602–614 (2000).
   PubMed Web of Science ®Google Scholar
• American College of Emergency Physicians Clinical Policies Committee; American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann. Emerg. Med.42(4), 530–545 (2003).
   PubMedGoogle Scholar
• Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr. Clin. North Am.53(2), 167–194 (2006).
   PubMedGoogle Scholar
• Ishimine P. The evolving approach to the young child who has fever and no obvious source. Emerg. Med. Clin. North Am.25(4), 1087–1115, vii (2007).
   PubMed Web of Science ®Google Scholar
• Bonsu BK, Chb M, Harper MB. Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann. Emerg. Med.42(2), 216–225 (2003).
   PubMedGoogle Scholar
• Berger RM, Berger MY, van Steensel-Moll HA, Dzoljic-Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur. J. Pediatr.155(6), 468–473 (1996).
   PubMedGoogle Scholar
• Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J. Pediatr.153(4), 570–574 (2008).
   PubMed Web of Science ®Google Scholar
• Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet341(8844), 515–518 (1993).
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab.79(6), 1605–1608 (1994).
   PubMed Web of Science ®Google Scholar
• Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr. Infect. Dis. J.27(7), 654–656 (2008).
   PubMedGoogle Scholar
• Sackett D, Haynes R, Guyatt G, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Lippincott Williams and Wilkins, Boston, MA, USA (1991).
   Google Scholar
• Olaciregui I, Hernandez U, Munoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch. Dis. Child.94(7), 501–505 (2009).
   PubMed Web of Science ®Google Scholar
• Schwartz S, Raveh D, Toker O, Segal G, Godovitch N, Schlesinger Y. A week-by-week analysis of the low-risk criteria for serious bacterial infection in febrile neonates. Arch. Dis. Child.94(4), 287–292 (2009).
   PubMed Web of Science ®Google Scholar
• Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics122(4), 701–710 (2008).
   PubMed Web of Science ®Google Scholar
• Hsiao AL, Chen L, Baker MD. Incidence and predictors of serious bacterial infections among 57- to 180-day-old infants. Pediatrics117(5), 1695–1701 (2006).
   PubMed Web of Science ®Google Scholar
• Bressan S, Andreola B, Cattelan F, Zangardi T, Perilongo G, Da Dalt L. Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever. Pediatr. Infect. Dis. J.29(3), 227–232 (2010).
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Haynes RB, Jaeschke RZ et al. Users’ Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users’ Guides to patient care. Evidence-Based Medicine Working Group. JAMA284(10), 1290–1296 (2000).
   PubMed Web of Science ®Google Scholar
• Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics108(2), 311–316 (2001).
   PubMed Web of Science ®Google Scholar
• Isaacman DJ, Shults J, Gross TK, Davis PH, Harper M. Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics106(5), 977–982 (2000).
   PubMed Web of Science ®Google Scholar
• Bleeker SE, Moons KG, Derksen-Lubsen G, Grobbee DE, Moll HA. Predicting serious bacterial infection in young children with fever without apparent source. Acta Paediatr.90(11), 1226–1232 (2001).
   PubMed Web of Science ®Google Scholar
• Bleeker SE, Derksen-Lubsen G, Grobbee DE, Donders AR, Moons KG, Moll HA. Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr.96(1), 100–104 (2007).
   PubMed Web of Science ®Google Scholar
• Galetto-Lacour A, Zamora SA, Andreola B et al. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source. Arch. Dis. Child. DOI:10.1136/adc.2009.176800 (2010) (Epub ahead of print).
   Google Scholar